Greedy design space construction based on regression and latent space extraction for pharmaceutical development

Abstract

Implementation of the design space (DS) is a scientific concept for ensuring quality to be submitted as a part of the regulatory filing of a drug product for approval to market. An empirical approach is constructing the DS based on the regression model whose inputs are process parameters and material attributes over the different unit operations, i.e., a high-dimensional statistical model. While the high-dimensional model assures quality and process flexibility through a comprehensive process understanding, it has difficulty visualizing the feasible range of input parameters, i.e., DS. Therefore, this study proposes a greedy approach to constructing the extensive and flexible low-dimensional DS based on the high-dimensional statistical model and the observed internal representations that satisfies both comprehensive process understanding and the DS visualization capability. Introducing the observed correlation structure enabled the dimensionality reduction of the DS. The non-critical controllable parameters were fixed to the target values in visualizing the low-dimensional DS as a function of critical parameters. The expected variation of non-critical non-controllable parameters was considered the source of variation in prediction. The case study demonstrated the proposed approach's usefulness for developing the pharmaceutical manufacturing process.

Keywords: Conditional risk assessment; Control strategy; Design space; Gaussian process regression; Principal component analysis.